NCT03105505View on ClinicalTrials.gov

The Efficacy of Permethrin 5%, Fusidic Acid 1% and Synthomycine 5% for Demodex - Blepharitis

PHASE4UnknownINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

April 28, 2017

Primary Completion Date

September 30, 2018

Study Completion Date

September 30, 2018

Conditions
Inflammation of the Eyelids
Interventions
DRUG

Permethrin 5%

Facial skin application once a night for 3 months.

DRUG

Synthomycine 5%

Eye ointment, eyelids and eyelashes application (chloramphenicol), once a night for 3 months.

DRUG

Fusidic Acid 1% M/R Eye Drops

viscous eye drops application once a night for 3 months.

Trial Locations (1)

78278

Barzilai Medical Center, Ashkelon

Sponsors
All Listed Sponsors
lead

Barzilai Medical Center

OTHER